Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
Key Clinical Message Development of noninvasive treatments for erythroplasia of Queyrat, a carcinoma in situ, is expected. This case suggests topical imiquimod might be a candidate with regimens consisting of much longer duration of the treatment than for genital warts and the maintenance phase of t...
Main Authors: | Maiko Yokoyama, Gyohei Egawa, Takamitsu Makino, Kiyofumi Egawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2076 |
Similar Items
-
Efficacy of topical photodynamic therapy in the treatment of erythroplasia of Queyrat
by: Massimo Iafrate, et al.
Published: (2020-06-01) -
The case of successful photodynamic therapy in patient with erythroplasia of queyrat
by: E. V. Filonenko, et al.
Published: (2014-06-01) -
Erythroplasia of Queyrat Treated with 5% Imiquimod Cream — Case Report Emphasizing the Role of Human Papilloma Virus Testing in a Clinical Setting
by: Chiriac Anca, et al.
Published: (2017-03-01) -
Photodynamic therapy opportunities for the treatment of erythroplasia of Queyrat
by: A. D. Kaprin, et al.
Published: (2020-04-01) -
Erythroplasia of Queyrat
by: Deirdre Mary Fanning, et al.
Published: (2012-06-01)